Immunodiffusion experiments were conducted to associate a precipitin line with Escherichia coli heat-labile enterotoxin (LT). Wild strains of porcine and of human enteropathogenic E. coli as well as laboratory-derived enterotoxigenic variants of E. coli K-12 were used for LT antigen preparations. These were produced mainly by ultrafiltration and ammonium sulfate precipitation of broth culture supernatants. When antisera with anti-LT activity were reacted with antigen preparations from Ent+ and Ent-variants of E. coli K-12, a line "a" was given by Ent+ but not by Ent-preparations. Line "a" was removed by absorption of anti-LT serum with antigen preparation from an Ent+ E. coli K-12, but was unaffected when the antigen preparation used to absorb the serum was from an Ent-E. coli K-12. A line identical to "a" was given by antigen preparations from wild strains of porcine enteropathogenic E. coli reacted with homologous or heterologous anti-LT sera. One human strain of enteropathogenic E. coli was shown to possess an antigen identical to that which gave rise to line "a." To demonstrate this line it was necessary to use high concentrations of gammaglobulin and high concentrations of the crude antigen preparations. LT preparations reacted with anticholera toxin to give a line "c," which showed a reaction of partial identity with line "b" produced by reaction of pure choleragenoid and anticholera toxin. Lines "a" and "c" gave reactions of identity.
The enterotoxin produced by Vibrio cholerae has been isolated in a pure form (4) and has been well characterized (9, 10) . In contrast, the enterotoxins produced by Escherichia coli have been neither isolated nor well characterized. Whereas a single enterotoxic substance is produced by V. cholerae, two classes of enterotoxins, one heat labile and the other heat stable, have been described for E. coli (5, 12, 13) .
The heat-labile E. coli enterotoxin (LT) bears an antigenic relationship to the enterotoxin of V. cholerae (6) . Also, LT is determined by a plasmid (11, 12, 14, 15) , and it is possible to produce pairs of E. coli strains that are isogenic except that one has an enterotoxin plasmid (Ent+) and the other lacks the plasmid (Ent-). These factors are utilized in the present study, designed to demonstrate a precipitin line for LT and to investigate antigenic relationships between LT and choleragen, between LT from various serotypes of porcine enteropathogenic E. coli, and between LT from human and porcine strains of E. coli. Additionally, electrophoresis and immunoelectrophoresis are applied to aid in the characterization of the E. coli heat-labile enterotoxin.
MATERIALS AND METHODS Bacterial cultures. E. coli cultures used for the preparation of antigens and the immunization of pigs were as follows. The Ent-K-12 strains used were 711 and CRM. The Ent+ K-12 strains used were 711(P307), 711(P155), 711(P130), 711(P25), 711(P116), and CRM(P75) (the donor strains are listed in parentheses). The Ent+ wild strains used as donors of Ent plasmids were P307, P155, P130, P25, P116, and P75; the Ent+ wild strains of porcine origin used for the immunization of pigs were P307, P155, P1253, P1108, P3111, and P491; the Ent+ wild strains used that were of human origin were H10407 (antiserum was produced against this strain), H339, and H410. Strain 711 was a nalidixic acid-resistant, lactose-negative, auxotrophic E. coli K-12, and CRM was a prototrophic colicin-resistant K-12. The Ent+ K-12 organisms were produced as previously described (12, 14) . The wild strains of porcine enteropathogenic E. coli represent nine serological types.
All strains with the "P" designation are porcine enteropathogens; those with the "H" are human enteropathogens.
Preparation of broth supernatant antigens. Two Ent and six Ent+ E. coli K-12 organisms (see above), six Ent+ porcine enteropathogens (P307, P155, P1253, P1108, P3111, and P491), and the three human enteropathogens were used for preparation of broth supernatant antigens. The medium in which these organisms were grown was syncase broth (3), modified by replacing 0.5% sucrose with 1.0% glucose, 1% Casamino Acids with 2%, and by addition of 0.01% tryptophane. The growth conditions were as described previously (8) except that the duration of incubation was 20 h. The cultures were usually grown in 5-or 10-liter batches, and at least two batches were produced for each organism. Six batches were prepared for E. coli strains 711 and 711(P307).
Cell-free broth culture supernatant was obtained by centrifugation followed by filtration through a 0.45-tsm cellulose acetate membrane filter. This broth culture supernatant was then subjected to repetitive concentration (by passage through a cellulose acetate filter with a molecular weight cut-off of 30,000) and dilution in 0.1 M tris(hydroxymethyl)-aminomethane (Tris)-chloride buffer, pH 8.0. The ultrafiltration was terminated when approximately 99.9% of the completely membrane-permeable constituents had been eliminated. The retentate was lyophilized and used as broth supernatant antigen. These preparations were reconstituted in distilled water at concentrations ranging from 200 to 400 mg/ml for use in immunodiffusion, immunoelectrophoresis, and electrophoresis. Preparations from enterotoxigenic organisms are referred to as tox+, and preparations from non-enterotoxigenic organisms are referred to as tox-.
Four batches of 711(P307) and 711(P155) broth supernatant, as well as one batch of supernatant from each of the strains P491, P307, and H10407, were subjected to precipitation with ammonium sulfate at 80% saturation. The precipitate was dissolved in 0.1 M Tris-chloride buffer, pH 8, and subjected to discontinuous ultrafiltration and subsequent freeze-drying as described above.
WCL antigen. Whole cell lysate (WCL) was prepared from E. coli 711(P307) as previously reported (6) (Gyles, in press ). The antiserum with the highest titer was that prepared against E. coli P491.
The gammaglobulin was precipitated from each serum by using 33% ammonium sulfate (1). The gammaglobulin was then freeze-dried. It was reconstituted in distilled water containing 0.1% sodium azide and stored at 5 C during use. The amount of water added effected a five-times concentration, compared with serum, for use in immunodiffusion, and a threetimes concentration for use in immunoelectrophoresis.
Anti-choleragenoid serum prepared in a horse (2) and anti-choleragenoid serum absorbed with choleragenoid were obtained from R. A. Finkelstein. Purifed horse cholera antitoxin was obtained from the Swiss Serum and Vaccine Institute (SSVI), Bern, Switzerland.
Absorption of antisera. Samples of the anti-LT gammaglobulin from E. coli P491 were absorbed with broth supernatant antigen preparations from the Ent-E. coli 711 and the Ent+ E. coli 711(P307). Freeze-dried gammaglobulin (50 mg) was dissolved in 10 ml of distilled water, and 50 mg of the antigen preparation was added. After incubation at 37 C for 2 h, the material was centrifuged at 40,000 x g for 20 min, and the processes of adding antigen, incubation, and centrifugation were repeated. The absorbed gammaglobulin was then passed through a 0.45-Am cellulose acetate membrane filter and concentrated by dialysis against Ficoll (Pharmacia, Uppsala, Sweden). Five-times concentrated gammaglobulin preparations were used for immunodiffusion and threetimes concentrated material was used for immunoelectrophoresis.
The SSVI chlora antitoxin was absorbed with E. coli 711 antigen preparation as follows. The 711 antigen (30 mg) was added to 1 ml of the antitoxin.
Two series of incubation and centrifugation were carried out as described above, and the material was filtered through a 0.45-,um cellulose acetate membrane filter.
Immundiffusion. Immunodiffusion tests were conducted in 0.65% agarose in 0.05 M Gelman high-resolution buffer (Tris-barbital-sodium barbital, pH 8. The electrode vessels contained 0.1 M high/resolution buffer, pH 8.8. E. coli antigen preparation (10 Aliters) was placed in the wells, and electrophoresis was conducted for 60 min at 9 V/cm. Concentrated anti-LT gammaglobulin or cholera antitoxin (60 iliters) was placed in the troughs, and the slides were incubated at room temperature and observed for 7 days.
On two occasions, after electrophoresis of a sample of enterotoxic E. coli 711(P307) antigen, the agarose was divided into seven 1-cm sections, so that the sample well was the center of one section. These sections of agarose were extracted with high-resolution buffer and tested in ligated segments of rabbit intestine.
Electrophoresis. Electrophoresis was carried out on cellulose acetate strips (Sepraphore III, Gelman, Ann Arbor, Mich.) in 0.05 M high-resolution buffer, pH 8.8, by using 300 V for 60 min. After electrophoresis, the strips were stained with Ponceau S. In two cases, an enterotoxic antigen preparation was applied as two adjacent spots. After electrophoresis, the strip was divided longitudinally and one-half was stained. The unstained half was cut into seven fractions corresponding to stained bands, and each fraction was eluted in high-resolution buffer.
Ligated intestine tests. Tests for enterotoxicity were conducted in ligated segments of rabbit intestine (7). The antigen preparations as well as material eluted from agarose and from cellulose acetate strips were tested for enterotoxicity.
Experiments. Immunodiffusion tests were designed to: (i) compare the precipitin lines given by Ent+ and Ent-E. coli antigen preparations reacted with antisera against Ent+ E. coli; (ii) determine the effect of absorption of an anti-enterotoxic serum with antigen preparation from Ent+ and Ent-E. coli on the lines produced in reactions with an Ent+ E. coli antigen preparation; (iii) compare the precipitin lines given by Ent+ and Ent-E. coli antigen preparations reacted with cholera antitoxin; (iv) compare the reactions of antigens from Ent+ porcine and human strains of E. coli reacted with cholera antitoxin; (v) compare the reactions of enterotoxin antigen preparations in homologous and heterologous anti-LT sera; and (vi) associate enterotoxic activity with a fraction of antigen preparation subjected to electrophoresis.
RESULTS
Antigen preparations. The yield of solid material from the broth supernatants ranged from 100 to 200 mg of broth per liter. Wild strains of E. coli, particularly those which were mucoid, usually gave larger quantities of material than did the E. coli K-12 organisms. Preparations of the Ent-E. coli K-12 were tested at 2-mg doses in ligated segments of rabbit intestine and were always negative. Preparations of the Ent+ organisms were always positive at a 1-mg dose and were tested at lower doses until a level was found at which the ligated rabbit loop response was less than 1 ml of fluid per cm of intestine. The most active preparation was a broth supernatant preparation of E. coli 711(P307) that gave reactions in excess of 1 ml/cm at a dose of 0.125 mg. There was only slight improvement in the specific activity of the enterotoxic broth supernatant antigen preparations as a result of the ammonium sulfate precipitation. The ammonium sulfate-precipitated WCL compared favorably with the broth supernatant preparations in enterotoxicity.
Immunodiffusion tests. P491 antiserum was reacted with broth supernatant antigen preparations from the Ent-E. coli K-12 strains and from the Ent+ variants of E. coli K-12. A precipitin line, "a," was observed to be given by all the preparations from the Ent+ K-12 strains and from all the strains of porcine enteropathogens and not by any of the preparations from the Ent-K-12 strains. This line is demonstrated in Fig. 1 . By reacting antigen preparations from strains 711 and 711(P307) with the six antisera against strains of porcine enteropathogenic E. coli, it was shown that a line identical to line "a" could be given by each antiserum. Line "a" was best developed, however, by use of the P491 antiserum.
P491 antisera in the unabsorbed state, ab-FIG. 1. Reaction of one non-enterotoxic (tox) and three porcine enterotoxic (tox+) antigen preparations with antiserum (AS) against a porcine enterotoxigenic E. coli (P491). The antigen wells (1 to 4) contained broth supernatant antigens prepared from E. coli strains 711, 711(P307), 711(P155), and 711(P116), respectively. Line "a" is given by the enterotoxic antigens but not by the non-enterotoxic antigen. 
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sorbed with an Ent-711 antigen preparation, and absorbed with an Ent' 711(P307) antigen preparation were reacted with an antigen preparation from E. coli strain 711(P307). The results of these tests are shown in Fig. 2 . A line consistent with line "a" is given by the unabsorbed P491 antiserum and by P491 antiserum absorbed with the Ent-antigen preparation but not by P491 antiserum absorbed with the Ent+ antigen preparation.
When antigen preparations from the Ent-E. coli strain 711 and from the Ent+ strain 711(P307) and choleragenoid were reacted with the SSVI anticholera toxin, the lines shown in Fig. 3 were obtained. Line "b" represents the reaction of pure choleragenoid with its antibody. Two lines were obtained with the enterotoxigenic antigen preparation and one line was obtained with the non-enterotoxigenic preparation. The line common to the tox+ and tox-antigen preparations was unrelated to the cholera toxin line. The line "c," which was not given by the preparation from the Ent-organism, gave a reaction of partial identity with the cholera toxin line, "b." The pattern illustrated in Fig. 3 was obtained for all preparations of Ent+ and Ent-E. coli K-12, in reactions with SSVI anticholera toxin.
When anti-choleragenoid serum was used instead of purified horse cholera antitoxin (SSVI) in the pattem illustrated in Fig. 3 3) . The line, which appears to be line "a" (Fig. 1) , is not given by the P491 serum absorbed with 711(P307) antigen. following results were obtained. The precipitin lines were the same as those shown in Fig. 3 except that the line common to the tox+ and tox-antigen preparations was absent, and the two lines that appeared (corresponding to lines "b" and "c") were weaker. Immunodiffusion tests were carried out to demonstrate that these two lines obtained with anti-choleragenoid serum were identical to the corresponding lines produced with the SSVI cholera antitoxin.
Of the antigen preparations from the human enteropathogenic E. coli, only those from strain H10407 were highly reactive in rabbit gut loops. Those from strain H339 required a 0.5-mg dose to give reactions of the order of 1 ml/cm, and those from strain H410 were much less active. When preparations from these three strains were reacted with P491 antiserum, a line identical to line "a" was given by the H10407 preparations but not by preparations from strains H410 and H339.
When 711(P307), H10407, and choleragenoid antigens were tested against SSVI anticholera toxin (Fig. 4) , a line identical to line "c"9 was given by the H10407 preparation. Antigen preparations from H10407 reacted with P491 antiserum to give a line identical to line "a." A line related to line "a" was not observed when the H10407 preparations were reacted with antiserum against E. coli H10407. When E. coli antigen preparations were tested against homologous antiserum, as many as six lines usually appeared. With certain combinations, however, only a few lines were visible and were often accompanied by a mass of precipitated material. Figure 5 illustrates such a homologous reaction involving antigen and antisera from E. coli P491. This homologous reaction gave a line identical to line "a," given by 711(P116) antigen and P491 antiserum. Line "a" is identical to line "c," given by 711(P116) antigen and SSVI anticholera toxin.
When choleragenoid was reacted with anti-LT sera, a weak precipitin line was obtained with two (P491 and P3111) of seven antisera. This precipitin line was always very close to the antiserum well and gave a reation of partial identity with the cholera toxin line. Because of the weakness of the line and its closeness to the antiserum well, it was not possible to determine its relationship to line "a."
Immunoelectrophoresis. Reactions of broth supernatant antigens from E. coli 711 and 811(P307) and of WCL antigen from 711(P307) are illustrated in Fig. 6 and 7. When P491 antiserum absorbed with 711 antigen was used (Fig. 6 ), a single line close to the point of sample application was given by antigen preparations from the Ent+ but not by antigen preparations from the Ent-organisms. FIG . 5 . Reactions of porcine anti-enterotoxic serum (P491) and SSVI anticholera toxin (anti-chol) with homologous and heterologous antigen preparations. The cholera toxoid line, "b," has a reaction of partial identity with line "c," given by the enterotoxic antigen 711(P116) (well 4) and anticholera toxin. Line "c" is identical to line "a," given by 711(P116) and P491 antiserum. Line "c" is also identical to a line given by antigen P491 (well 3) and antiserum P491. Furthermore, line "a" was identical to line "c," which was given by reactions of anticholera toxin with antigens from enterotoxigenic strains of E. coli, but not by reactions with antigens from non-enterotoxigenic strains. Line "c" (and therefore line "a") has a reaction of partial identity with the cholera toxin precipitin line "b." These findings strongly suggest that line "a" represents the reaction of E. coli heat-labile enterotoxin with its antibody.
The antigen giving rise to line "a" appeared to be identical in enterotoxic preparations from various serotypes of porcine enteropathogenic E. coli. There also appeared to be identity between the antigen in porcine and in human strains of enteropathogenic E. coli in reactions with antisera against porcine LT.
The observation of a spur formation between line "b" (the cholera toxoid line) and line "c" is consistent with the finding (Gyles, in press) that E. coli LT is neutralized by high dilutions of anticholera toxin, but cholera toxin is not neutralized to any significant extent by anti-E. coli LT. In that study it was also shown that absorption of cholera antitoxin with E. coli LT preparation removed the anti-E. coli LT but not the anticholera toxin activity of the serum. The results of both of these investigations indicate that there are antigens common to E. coli LT and V. cholerae enterotoxin that induce the formation of antibody that neutralizes the E. coli LT but not the V. cholerae enterotoxin.
The immunoelectrophoretic studies, combined with the tests for enterotoxicity of various electrophoresed fractions of toxin preparations, suggest that the line seen at the point of sample application is due to E. colC*enterotoxin. Failure to detect a band on cellulose acetate strips that could be associated with enterotoxin may be due to the presence of comparatively small amounts of toxin in the antigen preparations. Furthermore, a band at the point of application is easily obscured. It appears that preparative electrophoresis or other methods relying on the charge of the molecule may be useful in attempts to improve the specific activity of broth supernatant preparations.
Failure to detect a line that could be associated with enterotoxin in antigen preparations from the two human enteropathogens H410 and H339 was likely due to a low content of toxin in these preparations. When antigen preparations with higher specific activity are produced, the probability of demonstrating a precipitin line for enterotoxin in most strains of human enteropathogenic E. coli will be enhanced.
